RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,090,796 | -14.6% | 125,800 | -3.9% | 0.00% | – |
| Q2 2023 | $2,447,830 | -30.8% | 130,900 | -32.1% | 0.00% | -100.0% |
| Q1 2023 | $3,535,421 | -0.8% | 192,666 | +7.0% | 0.00% | 0.0% |
| Q4 2022 | $3,565,584 | -19.3% | 180,080 | -1.9% | 0.00% | 0.0% |
| Q3 2022 | $4,419,000 | +284.3% | 183,645 | +191.5% | 0.00% | – |
| Q2 2022 | $1,150,000 | -42.4% | 63,000 | -30.6% | 0.00% | – |
| Q1 2022 | $1,997,000 | -58.0% | 90,808 | -29.9% | 0.00% | – |
| Q4 2021 | $4,756,000 | +194.5% | 129,518 | +149.1% | 0.00% | – |
| Q3 2021 | $1,615,000 | -83.2% | 52,000 | -82.8% | 0.00% | -100.0% |
| Q2 2021 | $9,597,000 | +104.5% | 301,893 | +42.8% | 0.00% | – |
| Q1 2021 | $4,693,000 | +46.0% | 211,404 | +29.9% | 0.00% | – |
| Q4 2020 | $3,214,000 | – | 162,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $58,747,000 | 54.16% |
| KPCB XV Associates, LLC | 1,297,063 | $47,641,000 | 37.58% |
| Ponoi II Management, LLC | 145,401 | $5,341,000 | 9.70% |
| Euclidean Capital LLC | 432,900 | $15,900,000 | 9.04% |
| Column Group LLC | 1,402,008 | $51,496,000 | 7.00% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,655,000 | 5.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $42,178,000 | 4.85% |
| Ghost Tree Capital, LLC | 350,000 | $12,856,000 | 4.61% |
| Velan Capital Investment Management LP | 110,000 | $4,040,000 | 3.14% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $16,294,000 | 2.28% |